Predicting central nervous system relapse in primary breast diffuse large B-cell lymphoma using the stage-modified IPI score: A retrospective cohort study
Objective: The existing Central Nervous System-International Prognostic Index (CNS-IPI) provides insufficient guidance for predicting central nervous system (CNS) relapse in individuals with primary breast diffuse large B-cell lymphoma (DLBCL). This retrospective cohort study sought to examine the p...
Main Authors: | Guang-Liang Chen, Pin Guo, Jin Wang, Bao-Hua Yu, Xiaonan Hong, Junning Cao, Fangfang Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024028263 |
Similar Items
-
CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS IN PRIMARY BREAST DIFFUSE LARGE B-CELL LYMPHOMA
by: guangliang Chen, et al.
Published: (2022-08-01) -
New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study
by: Qing-Qing Cai, et al.
Published: (2016-09-01) -
External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free survival
by: Naree Warnnissorn, et al.
Published: (2022-12-01) -
Developing New Strategies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
by: Eva Gonzalez Barca
Published: (2023-11-01) -
The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma
by: Tingxun Lu, et al.
Published: (2023-08-01)